skip to Main Content
about

IMAGING ENDPOINTS

We are the world’s largest oncology focused imaging CRO (iCRO); we specialize in developing and deploying optimal imaging in early to late-stage clinical trials and supporting regulatory submissions.

Scottsdale

Imaging Endpoints is based in Scottsdale, Arizona where we serve the West Coast and the Midwest of the United States as well as the Pacific Rim.

Cambridge

We also have an East Coast office in Cambridge, Massachusetts where we serve the Boston biotechnology sector, the East Coast of the United States and Europe.

Iep Map

We have staff strategically located in Europe and Asia to serve over 40 countries with offices in India, the Netherlands, Switzerland and new offices in China and London.

We are an affiliate of HonorHealth, home to the Virginia G. Piper Cancer Center and one of the largest healthcare systems nationally. We are also an affiliate of Southwest Medical Imaging, Ltd. (SMIL / RadPartners), ranked as the largest private radiology group in the United States and home to >40 of our 200+ radiologists.

Points of Excellence

deep science

Deep Science

IE’s experience spans hundreds of successful studies across all phases of development, including the most complex, high-profile Phase 3 trials and new drug approvals in the industry.

readers

Expert Readers

Our team includes over 200 physician readers comprised of >40 in-house radiologists and the world’s leading academically-based expert radiologists, oncologists, surgeons and other physicians.

services

Global Services

We are the largest global imaging CRO focused in oncology. We receive/read scans in real-time from hundreds of imaging sites in over 40 countries.

standards

Setting New Quality Standards

Our imaging Quality Management System (iQMS) is designed to exceed industry standards. All inspections by FDA and EMEA have resulted in zero observations, clearly demonstrating our industry leadership in quality.

stability

Exceptional Stability

IE has experienced over a decade of high growth with no ownership change or executive leadership change.

Have a question or want to tell us about your study?

Please contact us and one of our representatives will contact you to arrange a call with our Chief Medical Officer, Ronald Korn, MD, PhD and his team of expert imaging scientist and operations specialists.

LATEST HEADLINES

Improving Outcomes in Chronic Lymphocytic Leukemia Trials Through the Integral Role of BICR in Imaging Assessments

December 17, 2024

MORE

Clinical Endpoints: An SMO Connecting Patient’s to Hope

November 26, 2024

MORE

BICR Approaches in Hepatocellular Cancer Clinical Trials with Emerging Therapies

November 5, 2024

MORE
Back To Top